Skip to content

Featured Articles

WBA’s Q4 earnings top analysts’ forecast

WBA’s Q4 earnings top analysts’ forecast

Walgreens Boots Alliance (WBA) beat Wall Street’s adjusted earnings per share forecast for its 2017 fourth quarter and fiscal year, with pharmacy results helping boost sales for both periods. However, WBA said Wednesday that costs related to the unsuccessful deal to acquire Rite Aid Corp.

McKesson U.S. Pharmaceutical president to depart

McKesson U.S. Pharmaceutical president to depart

McKesson U.S. Pharmaceutical president Mark Walchirk is leaving the company to become president and chief executive officer of Patterson Companies Inc., a distributor serving the dental and animal health markets. Patterson said Tuesday that Walchirk is slated to start at the company on Nov. 20.

Publix proceeds with innovative care partnership

Publix proceeds with innovative care partnership

Publix Pharmacy has in place the first piece of a three-pronged partnership with BayCare Health System, which serves the Tampa Bay and central Florida region. Publix Super Markets Inc. said Thursday that Publix retail pharmacies are now open at St. Anthony’s Hospital’s Suncoast Medical Clinic in St.

Jean Coutu Group tallies 2Q sales gains

Jean Coutu Group tallies 2Q sales gains

Retail and corporate sales climbed at Jean Coutu Group in the fiscal 2018 second quarter, the first reporting period since its $4.5 billion (Canadian) deal to be acquired by Metro Inc. Net profit per share in the quarter ended Sept.

Domenic Pilla tabbed as McKesson Canada CEO

Domenic Pilla tabbed as McKesson Canada CEO

McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will

Rite Aid sales, earnings decline in third quarter

Rite Aid sales, earnings decline in third quarter

Rite Aid Corp. said slim reimbursement rates, new generic drugs and the ongoing antitrust talks for the merger with Walgreens Boots Alliance (WBA) squeezed sales and earnings for its fiscal 2017 third quarter. Rite Aid said Thursday that for the third quarter ended Nov. 26, sales dipped 0.8% to $8.